Serlopitant 5 mg vs placebo
Serlopitant 5 mg may leads to higher patient‐reported pruritus intensity compared with placebo (low certainty).
- RR 2.06 [1.27, 3.35]1 study · 126 participantsLow
Serlopitant 5 mg may leads to higher patient‐reported pruritus intensity compared with placebo (low certainty).
It is very uncertain whether serlopitant 5 mg changes adverse events compared with placebo (very low certainty).
It is very uncertain whether serlopitant 5 mg changes sleep disturbances: number of participants with insomnia compared with placebo (very low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
It is very uncertain whether serlopitant 1 mg changes sleep disturbances: number of participants with insomnia compared with placebo (very low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
Serlopitant 1 mg showed no clear difference in patient‐reported pruritus intensity compared with placebo (low certainty).
It is very uncertain whether serlopitant 1 mg changes adverse events compared with placebo (very low certainty).
Serlopitant 0.25 mg showed no clear difference in patient‐reported pruritus intensity compared with placebo (low certainty).
It is very uncertain whether serlopitant 0.25 mg changes adverse events compared with placebo (very low certainty).
It is very uncertain whether serlopitant 0.25 mg changes sleep disturbances: number of participants with insomnia compared with placebo (very low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.